Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where procedure solutions remain limited. Utilize the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/4otc-appoints-kyle-jannece-as-head-of-business-development/